Genetics and age-related macular degeneration: a practical review for the clinician
- PMID: 27445455
- PMCID: PMC4938141
- DOI: 10.2147/OPTH.S109723
Genetics and age-related macular degeneration: a practical review for the clinician
Abstract
Age-related macular degeneration is a complex disease, with both genetic and environmental risk factors interacting in unknown ways. Currently, 52 gene variants within 34 loci have been significantly associated with age-related macular degeneration. Two well-studied major genes are complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2). There exist several commercially available tests that are proposed to stratify patients into high-risk and low-risk groups, as well as predict response to nutritional supplementation. However, at present, the bulk of the available peer-reviewed evidence suggests that genetic testing is more useful as a research tool than for clinical management of patients.
Keywords: ARMS2; CFH; age-related macular degeneration; age-related maculopathy susceptibility 2; complement factor H; pharmacogenetics; vascular endothelial growth factor.
References
-
- Stone EM, Aldave AJ, Drack AV, et al. Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing. Ophthalmology. 2012;119(11):2408–2410. - PubMed
-
- Stone EM, Aldave AJ, Drack AV, et al. Recommendations of the American Academy of Ophthalmology task force on genetic testing. [Accessed June 23, 2016]. Available from: http://www.aao.org/clinical-statement/recommendations-genetic-testing-of.... - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
